Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes

Phosphatidylcholines (1-O-alcoxy-2-amino-2-desoxy-phosphocholines and 1-pyrene-labeled analogs) were synthesized and used to examine interactions with recombinant human PAF-acetylhydrolase (PAF-AH), an enzyme purified from plasma, and with macrophage-like U937 cells. Novel phosphatidylcholines conta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Deigner, Hans-Peter (VerfasserIn) , Kinscherf, Ralf (VerfasserIn) , Claus, Ralf (VerfasserIn) , Fyrnys, Beatrix (VerfasserIn) , Blencowe, Christopher (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 May 1999
In: Atherosclerosis
Year: 1999, Jahrgang: 144, Heft: 1, Pages: 79-90
ISSN:1879-1484
DOI:10.1016/S0021-9150(99)00034-9
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/S0021-9150(99)00034-9
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0021915099000349
Volltext
Verfasserangaben:Hans P. Deigner, Ralf Kinscherf, Ralf Claus, Beatrix Fyrnys, Christopher Blencowe, A. Hermetter

MARC

LEADER 00000caa a2200000 c 4500
001 1563497239
003 DE-627
005 20230427122057.0
007 cr uuu---uuuuu
008 170914s1999 xx |||||o 00| ||eng c
024 7 |a 10.1016/S0021-9150(99)00034-9  |2 doi 
035 |a (DE-627)1563497239 
035 |a (DE-576)493497234 
035 |a (DE-599)BSZ493497234 
035 |a (OCoLC)1340979389 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Deigner, Hans-Peter  |d 1958-  |e VerfasserIn  |0 (DE-588)1012570606  |0 (DE-627)699716705  |0 (DE-576)345618505  |4 aut 
245 1 0 |a Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes  |c Hans P. Deigner, Ralf Kinscherf, Ralf Claus, Beatrix Fyrnys, Christopher Blencowe, A. Hermetter 
264 1 |c 20 May 1999 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.09.2017 
520 |a Phosphatidylcholines (1-O-alcoxy-2-amino-2-desoxy-phosphocholines and 1-pyrene-labeled analogs) were synthesized and used to examine interactions with recombinant human PAF-acetylhydrolase (PAF-AH), an enzyme purified from plasma, and with macrophage-like U937 cells. Novel phosphatidylcholines containing a sn-2-carbamoylester group such as 1-O-hexadecyl-2-desoxy-2-amino-methylcarbamoyl-2-methyl-rac-glycero-3-phosphocholine 11 were found to act as site-specific irreversible enzyme inhibitors with Ki-values up to 83 (Kirev) and 177 (Ki(inact)) μm. The compounds exhibit only marginal inhibition of Ca2+-dependent phospholipases. Kinetic data show that phosphocholines carrying a terminal sn-1-pyrene moiety inhibit PAF-AH activity with an effectivity similar to analogs with an aliphatic chain. 1-O-Decyloxy-[10-(4-pyrenyl)-butoxy]-2-desoxy-2-amino-carbamoyl-methyl-rac-glycero-3-phosphocholine 13 could be used for enzyme labeling and to demonstrate an inhibitor-enzyme stoichiometry of 0.7:1. At 8°C, the compound accumulated in the membranes of U937 cells, at 37°C it was internalized into intracellular compartments. Structure-activity studies in a mixed micelle assay indicated that the inhibition power of reversible and irreversible inhibitors increases along with the (sn)-1-chain length similar to the structure-dependent binding of ether phospholipids to the PAF-receptor. Unlike the situation at the (sn)-1-position, increasing chain length at the sn-2-position, or an alkyl branching of the glycerol backbone significantly reduced the inhibitory potency. 
650 4 |a Fluorescence 
650 4 |a Inhibitors 
650 4 |a Macrophages 
650 4 |a Platelet-activating factor acetylhydrolase 
700 1 |a Kinscherf, Ralf  |e VerfasserIn  |0 (DE-588)1084823748  |0 (DE-627)848747925  |0 (DE-576)169729516  |4 aut 
700 1 |a Claus, Ralf  |d 1967-  |e VerfasserIn  |0 (DE-588)122036441  |0 (DE-627)705746828  |0 (DE-576)293060630  |4 aut 
700 1 |a Fyrnys, Beatrix  |e VerfasserIn  |0 (DE-588)1139852442  |0 (DE-627)897758382  |0 (DE-576)17446200X  |4 aut 
700 1 |a Blencowe, Christopher  |d 1966-  |e VerfasserIn  |0 (DE-588)120063875  |0 (DE-627)696347261  |0 (DE-576)292021364  |4 aut 
773 0 8 |i Enthalten in  |t Atherosclerosis  |d Amsterdam [u.a.] : Elsevier Science, 1970  |g 144(1999), 1, Seite 79-90  |h Online-Ressource  |w (DE-627)306654091  |w (DE-600)1499887-7  |w (DE-576)081984545  |x 1879-1484  |7 nnas  |a Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes 
773 1 8 |g volume:144  |g year:1999  |g number:1  |g pages:79-90  |g extent:12  |a Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes 
856 4 0 |u http://dx.doi.org/10.1016/S0021-9150(99)00034-9  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0021915099000349  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170914 
993 |a Article 
994 |a 1999 
998 |g 120063875  |a Blencowe, Christopher  |m 120063875:Blencowe, Christopher  |d 160000  |d 160100  |e 160000PB120063875  |e 160100PB120063875  |k 0/160000/  |k 1/160000/160100/  |p 5 
998 |g 1139852442  |a Fyrnys, Beatrix  |m 1139852442:Fyrnys, Beatrix  |d 160000  |d 160100  |e 160000PF1139852442  |e 160100PF1139852442  |k 0/160000/  |k 1/160000/160100/  |p 4 
998 |g 122036441  |a Claus, Ralf  |m 122036441:Claus, Ralf  |d 160000  |d 160100  |e 160000PC122036441  |e 160100PC122036441  |k 0/160000/  |k 1/160000/160100/  |p 3 
998 |g 1084823748  |a Kinscherf, Ralf  |m 1084823748:Kinscherf, Ralf  |d 50000  |d 53100  |e 50000PK1084823748  |e 53100PK1084823748  |k 0/50000/  |k 1/50000/53100/  |p 2 
998 |g 1012570606  |a Deigner, Hans-Peter  |m 1012570606:Deigner, Hans-Peter  |d 160000  |d 160100  |e 160000PD1012570606  |e 160100PD1012570606  |k 0/160000/  |k 1/160000/160100/  |p 1  |x j 
999 |a KXP-PPN1563497239  |e 2980260673 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Deigner, Hans-Peter","role":"aut","family":"Deigner","given":"Hans-Peter"},{"role":"aut","display":"Kinscherf, Ralf","roleDisplay":"VerfasserIn","given":"Ralf","family":"Kinscherf"},{"role":"aut","display":"Claus, Ralf","roleDisplay":"VerfasserIn","given":"Ralf","family":"Claus"},{"family":"Fyrnys","given":"Beatrix","roleDisplay":"VerfasserIn","display":"Fyrnys, Beatrix","role":"aut"},{"role":"aut","display":"Blencowe, Christopher","roleDisplay":"VerfasserIn","given":"Christopher","family":"Blencowe"}],"title":[{"title_sort":"Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes","title":"Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes"}],"note":["Gesehen am 14.09.2017"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1563497239","name":{"displayForm":["Hans P. Deigner, Ralf Kinscherf, Ralf Claus, Beatrix Fyrnys, Christopher Blencowe, A. Hermetter"]},"origin":[{"dateIssuedDisp":"20 May 1999","dateIssuedKey":"1999"}],"id":{"doi":["10.1016/S0021-9150(99)00034-9"],"eki":["1563497239"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedDisp":"[1970?]-"}],"id":{"issn":["1879-1484"],"eki":["306654091"],"zdb":["1499887-7"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 14.10.2020"],"disp":"Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probesAtherosclerosis","language":["eng"],"recId":"306654091","pubHistory":["Nachgewiesen 11.1970 -"],"part":{"pages":"79-90","issue":"1","year":"1999","extent":"12","text":"144(1999), 1, Seite 79-90","volume":"144"},"title":[{"title_sort":"Atherosclerosis","title":"Atherosclerosis"}]}]} 
SRT |a DEIGNERHANNOVELREVER2019